Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Dyax and Tularik establish drug discovery collaboration

Oct. 28, 1997

Structure of NO-producing enzyme solved

Oct. 28, 1997

Sibia's TBA technology licensed to Neurocrine Biosciences

Oct. 28, 1997

Atlantic's 2-5A improves efficacy of antisense compounds

Oct. 24, 1997

CombiChem/Athena initiate CNS drug discovery collaboration

Oct. 21, 1997

Aurora Biosciences licenses fluorescent technology from the University of California

Oct. 21, 1997

PharmaPrint and AHP to collaborate on herbal products

Oct. 20, 1997

Promising preclinical data for Inex's gene delivery system

Oct. 16, 1997

Genetronics evaluates its electroporation therapy in phase II

Oct. 16, 1997

Cell Genesys receives notice of patent claims for retroviral gene therapy vectors

Oct. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...